About
Joined TVM in 2020 with preclinical drug development expertise spanning hit identification through IND-enabling studies. Worked six years as a preclinical scientist at pharmaceutical startups Versantis and Mperia Therapeutics. Holds a Ph.D. in biopharmacy from the University of Paris-Saclay.
Colleagues at TVM Capital
Amy Kao
Senior Associate at TVM Capital
Barbara Hauser
Senior Accountant at TVM Capital
Dominique Larose
Assistant to Montreal Team at TVM Capital
Dr. Hubert Birner
Managing Partner at TVM Capital
Dr. Luc Marengère
Managing Partner at TVM Capital
Hubert Birner
Managing Partner at TVM Capital
Ivan T. Shaw
Principal at TVM Capital
Ivan T. Shaw, PhD
Principal at TVM Capital